Jobs Board
Log In Become a Member
Knowledge Exchange UK
Jobs Board
Log In Become a Member
  • Home
  • Membership
    • hidden – do not delete
  • Learn & Develop
    • hidden – do not delete
  • Events
    • hidden – do not delete
  • News
    • Member News
  • Resources
    • hidden – do not delete
  • Home
  • Membership
    • Why Join Us?
    • Become a member
    • Members Directory
  • Learn & Develop
    • Book a course
    • In-House Training
  • Events
    • Conference
    • KE Awards
    • Directors’ Forum
    • Online Events
  • Resources
    • Blog
    • Reports
    • Webinars
  • About
    • About Us
    • Brand Guidelines
    • Work with us
    • What is Knowledge Exchange?
  • KE Concordat
    • About
    • The 8 Guiding Principals
  • Jobs Board
  • Social Ventures and SHAPE
Log In Become a Member
Membership
Join our community of knowledge exchange professionals and access exclusive resources, events, and networking opportunities.
Become a member
Be part of our community
Why Join Us?
Become a member
Renew your membership
Members Directory
Member Events
Online Community
Communities & Groups
Resources
Browse our resources for blogs, news articles and all the information, advice and support you need in knowledge exchange and commercialisation.
View all resources
Media
News Articles
Blogs
Webinars
Reports
Topic Hubs
KE Concordat
KE Matters
AI
Government
Funding
Inclusion and diversity
Knowledge Exchange
Technology Transfer
Intellectual Property
SHAPE
Spinouts
Sustainability
Events
Join our networking events, including annual conference, KE Awards, Directors' Forum, and a variety of member-only gatherings.
View our events
Conference
Overview
Abstracts
Sponsorship
KE Awards
Attend
Finalists
Supporters & Sponsors
Judging Panel
Events
All Events
Directors' Forum
KE Matters
Learn & Develop
Continue your professional development with our training courses, workshops, and tailored in-house training designed to enhance your skills and knowledge.
Find out more
Our Courses
Fundamentals of Technology Transfer
Research Contracts
Practical Business Development
Spinout Creation
Software Commercialisation
Negotiation for Knowledge Exchange Professionals
Commercialisation in Healthcare
Establishing and Growing a Successful TTO
Practical Licensing
Developing Strategic Partnerships
New to Knowledge Exchange Programme
Leadership in Knowledge Exchange
Knowledge Exchange for Academics
Fundamentals of IP
CPD Opportunities
Book onto a training course
In-House Training
Mentoring
Become a volunteer
Apply for RTTP

Contact Us

+44 (0)1223 776130
info@ke.org.uk

St John's Innovation Centre
Cowley Rd,
Milton,
Cambridge,
CB4 0WS

Follow Us

Content Category: Guest Blog

Home > Guest Blog

To celebrate International Women’s Day, we interviewed a few remarkable women in the knowledge exchange (KE) sector to gain insight into their experiences, achievements, and the challenges they have overcome in their careers. This blog series highlights their views and stories, showcasing the incredible contributions women continue to make in KE. Join us as we celebrate their journeys and recognise the pivotal roles they play in shaping the future of knowledge exchange.

This blog is written by Jaci Barnett, a Course Director at Knowledge Exchange UK (KEUK).

Jaci Barnett, Chief Operating Officer at Oxford University Innovation, brings over 20 years of experience in research commercialisation and technology transfer. Jaci Barnett has managed tech transfer offices, launched innovation initiatives, and held executive and non-executive roles in spinouts. A Registered Technology Transfer Professional, Jaci Barnett is currently pursuing a PhD at the University of Bristol on spinout impact metrics.

(more…)

Home > Guest Blog

Christine Martin

To celebrate International Women’s Day, we interviewed a few remarkable women in the knowledge exchange (KE) sector to gain insight into their experiences, achievements, and the challenges they have overcome in their careers. This blog series highlights their views and stories, showcasing the incredible contributions women continue to make in KE. Join us as we celebrate their journeys and recognise the pivotal roles they play in shaping the future of knowledge exchange.

This blog is written by Christine Martin, a Course Director at Knowledge Exchange UK (KEUK).

Christine Martin is Head of Life Science Investment with a focus on drug discovery, managing a portfolio of technologies from University of Cambridge spin-outs. With extensive experience in life sciences tech transfer, she has worked on key projects, including the University of Cambridge-GSK open innovation initiative. Christine Martin holds an MA and DPhil from the University of Oxford and has authored over 20 peer-reviewed articles and patents.

(more…)

Home > Guest Blog

How things change. Barely three months later and the world had turned upside down, or at least had gone into a state of paralysis never seen before.

Like any business that was able to keep operating during the pandemic, our initial priorities revolved around transitioning to remote working and managing the anxieties of employees who were faced with a raft of challenges, both professional and personal. The impact on our core business activities – IP commercialisation, academic consultancies and new venture formation – was an open question, and we searched for indicators that might provide clues on what the coming months would bring.

The canary in the coalmine turned out to be the consultancy projects that academics undertake for external organisations, and for which OUI provides an optional service. From a healthy March we saw in April a precipitous (approx. 50%) decline in new enquiries from academics, contract terminations and a significant associated drop in income. Not far behind in terms of timing came reports of potential issues associated with spinout companies – principally those needing to raise investment in the next 6 months.

However, in common with many of our peers, we started to see an influx of new Covid-19 related IP disclosures and an associated prioritisation of our resources to progress these as quickly as possible. The University’s research engine had – in remarkably agile fashion – pivoted to address diverse challenges associated with the pandemic; everything from vaccines to rapid diagnostics, ventilators to remote monitoring technologies, and a wave of new IP was heading in our direction.

 

Sending out the lifeboats

When this wave first loomed on the horizon, it became apparent that our commercialisation activities would need to keep pace with the incredible speed at which the innovations from Oxford research were hitting escape velocity, and that “normal” technology transfer timelines would need to be compressed in an unprecedented manner. We concluded that setting clear expectations both internally and externally was going to be important in helping expedite access to relevant IP.

To achieve this, and in concert with colleagues in the University, OUI created a set of guidelines to cover the commercialisation of Covid-19 related innovations – published here:  https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/ We were not alone in such an approach – several of the top US universities launched similar initiatives around the same time and others in Europe have followed suit, mostly built on non-exclusive royalty-free licensing principles.

OUI’s intention was not to be rigidly prescriptive in how we would apply these principles, but instead to provide a default starting position; one intended to accelerate the negotiation process that – often for good reason – characterises IP transactions. Above all else, we sought to achieve one overarching objective; to ensure that as many people as possible could benefit as quickly as possible from our innovations.

Beneath this headline principle we offered non-exclusive royalty-free licences for the period of the pandemic but expected licensees to ensure that licensed technologies were made available in a manner that supported truly global equitable access, and that lower-income countries were not disadvantaged. Post-pandemic activity would be subject to more normal licensing terms. However, we recognised that different technologies would probably require different terms, especially products that would require large investments by licensees, so the overarching principle of global deployment at scale would always trump specific structural elements.

More than three months on from launching these guidelines, how effective have they been?

One observation is that they helped put a spotlight on OUI’s role in supporting Oxford’s academics in tackling the Covid-19 crisis and sent a message to the wider world that we were intent on being part of the solution. They helped set expectations both internally and externally, although admittedly there was confusion amongst some academics as to whether they were hard policy or more flexible guidelines.

The principles have also been incorporated for the most part intact into transactions for Covid-19 related IP. While terms of specific deals remain confidential, the vast majority of transactions completed have been materially different to “normal” licensing deal structures.

For example, they have differentiated between pandemic and post-pandemic periods, and have included much more stringent diligence obligations around access and affordability, including commitments to supply on a not-for-profit basis. Not all the licenses granted have been non-exclusive, but where exclusive rights have been granted, these have been coupled variously to rights for OUI to terminate, to convert to non-exclusive or to step in; each in cases where the licensee is failing to meet its diligence obligations.

 

Lessons learned?

Well, there have been a few. Firstly, the principles as drafted were best suited to more mature technologies and especially software. This was particularly true in relation to licensing non-exclusively.

Second, while the differentiation between pandemic and post-pandemic periods was helpful in many respects (e.g. structuring financial terms, higher levels of diligence obligations in the former), actually defining the end of the pandemic was a real challenge as there were no good historical precedents to rely upon. While it was acknowledged that the World Health Organisation would probably specify a point in time at which it was over, confidence amongst licensees was relatively low that this would be clear or appropriate. In some cases, it was easiest to kick this issue down the road and/or to rely on expert determination.

The outputs have also been varied in terms of routes to commercialisation. While we were originally expecting most to be licence deals to existing companies, we have also seen two new entities created/about to be created; both social enterprises – one to commercialise a rapid RT-LAMP diagnostic test for the virus, the other in support of the OxVent ventilator collaboration with Kings College and Smith & Nephew. The social enterprise model for which OUI has developed specific support over the last couple of years has also resonated with academics associated with other pipeline Covid-19 projects, and it was interesting to note that the other leading UK vaccine candidate, developed at Imperial College, is being commercialised via this route.

 

A new normal

What aspects of our response to the pandemic might apply once the world returns to normal? Could we not move as quickly to expedite licences outside a pandemic scenario? Surely our overarching principle should apply to any technology we manage? And what will a recovery look like for OUI as a business?

While it might surprise some, TTOs dislike unnecessary bureaucracy as much as anyone, and it has been refreshing to be able to move at such pace in the last few months. However, this has been enabled by both OUI and our licensees changing attitudes to risk and prioritising more ruthlessly than is normally possible. While we will continue to identify ways of accelerating transactions – for instance via the use of our online software store and creative allocation of resources to priority projects – much will depend on the extent to which licensees fall back into more normal timelines and processes, and how high a priority accessing Oxford IP is compared to all the other corporate activities competing for people’s time and resources. It really does take two to tango.

Three months after the start of lockdown, we still have relatively few data points from which to infer a recovery trajectory across the business. Our Licensing & Ventures teams remain very busy, some on Covid-19 projects but many not. From an alarming March, our Consulting Services group has seen a modest improvement in May and a surge in enquiries in June. Whether this is indicative of a rapid and sustained recovery, time will tell. Our spinout pipeline remains robust, but we expect an increased proportion in the coming months to take adopt a lean spinout model, bootstrapping wherever possible. Ultimately much will depend on the prevailing macroeconomic conditions, which look ominous.

 

Back to school?

Potential licensing efficiencies aside, it is likely that we will see profound changes in the way that we work. Like many others, we have over the years provided an increasingly flexible working environment for our staff, and our underlying systems and hardware have evolved to support remote working; for example, moving largely to the cloud (a prescient move for which our IT Manager deserves great credit!). This bold experiment of 100% remote working was implemented in a manner that would have been hard to envisage in normal times but, encouragingly, it has worked, in that productivity and outputs have remained high, despite many colleagues balancing work with childcare and schooling demands.

At the time of writing government advice remains that those who can work from home should do so, and I expect us to continue in this vein for some time yet. However, when we are all able to return to the office, a very different pattern is likely to emerge; one that involves more colleagues spending more time each week working remotely.

The perceived tension between home working and our core business has always been to what extent the former compromises the quality of interaction with academic colleagues – knowledge exchange is, of course, a contact sport. The pandemic has shown that good quality interaction and engagement can be maintained in a virtual manner that many – myself included – thought impossible, and we should take advantage of this to leverage the clear environmental and wellbeing benefits associated with home working.

We continue to engage regularly with our staff to shape our thinking on what the right balance would be. My current expectation is a more blended approach rather than a shift to 100% home working. While we are embracing a brave new world of opportunity associated with Teams, Zoom etc, I’m also conscious that one of OUI’s greatest sources of resilience during the pandemic has been a supportive, cohesive and collegiate culture, built over several years, that has helped some colleagues cope with extremely challenging personal circumstances. Finding a balance that maintains this culture will be critical in our future success as a company.

 

Opportunity for UK Knowledge Exchange

Thus far, the pandemic has, of course, resulted in widespread economic woes and, for many, tragic personal circumstances. For Oxford and the wider UK university community, it has represented a chance to step up and show just how agile, adaptable and effective we can be at solving problems that truly matter to society, and for knowledge exchange professionals to play a small but vital role in enabling this to happen. It has been a learning experience for all of us, and while the KE community will need to wait until 2021 to come together to discuss in person at the annual Praxis Auril conference, there is already much sharing of experiences online.

While our parent institutions – and indeed charitable research funders – unquestionably face significant financial challenges in the future, I look forward to continuing to reflect on the experiences of the pandemic, to learn and to share. By doing so we can hopefully ensure that the importance of university KE is recognised fully not only by us as practitioners, but by government and – perhaps most importantly – by the general public who stand to benefit most from the impact of our efforts.

Written by: Dr Adam Stoten RTTP, COO, Oxford University Innovation

 

Home > Guest Blog

We know the UK has been punching above its weight and now ranks 5th in the Global Innovation rankings. The proportion of R&D funding contributed by industry in the UK is 15% higher than in the US.  Over £40bn has been invested in UK universities over the past ten years by businesses and other organisations to find solutions to their business problems. Last year there were over 350,000 contracts between universities and businesses. And the spin-out race between the UK and US is neck and neck with UK investments in spin-outs beginning to edge ahead.

Earlier this month, the PraxisAuril Board gathered for its annual Strategy Awayday to reflect on our progress and shape the future.  We were delighted to welcome the CBI, InnovateUK, NCUB, UUK, the British Business Bank, ARMA and Research England around our table to share their views of the opportunities, challenges and the big issues in knowledge exchange. Graeme Reid – wearing multiple hats, as is customary – also gave us food for thought. 

One of the great challenges about KE is that it encompasses so many types of activity. PraxisAuril wants to ensure that it offers something for all its members. But we also want to have a well defined ‘voice’ that articulates the value of our training, advocacy, and networking activities as part of the UK’s world-leading knowledge exchange community.

It was clear that we have a major opportunity to think about how our world-leading expertise in effective knowledge exchange could be a real asset to UK plc in its attempts to attract inward investment and to build integrated innovation ecosystems.  PraxisAuril can help by ‘flaunting’ the role of KE in the innovation economy and building up our international profile as a successful exporter of expertise through our training around the World. 

We also agreed to build on our successful training programmes (more than 5600 people trained so far) by developing even bigger banks of useful ‘how-to’ stories and case studies of success.

Joining us this year were two new appointments to the PraxisAuril Board: Amanda Selvaratnam, Head of Enterprise Services at the University of York who led our conference committee in 2019 and won the member-elected seat in a hard-fought election; and Andy Walsh, Director of Academic Liaison at GSK, who has been appointed to ensure a business ‘user’ view. Iain Thomas, Head of Life Sciences at Cambridge Enterprise took up his seat as Chair-elect – his tenure will start in January 2021. 

So, it is time to be visionary and bold in our ‘ask’ for the role of KE in delivering the UK’s vision for a productive economy and global reach: time to take a leaf from our American cousins who confidently celebrate the achievements of the sector in their annual licensing survey; time to promote the contribution of all of PraxisAuril’s members up and down the UK; and time to assert the role of world-class development across a global professional network that has the potential to drive  UK research and innovation to new levels. 

 

Sean Fielding RTTP
Chair, PraxisAuril 2019-21

Director, Innovation, Impact and Business 
University of Exeter

 

Home > Guest Blog

In 2019 a new colleague joined our KTO office – so myself together with my fellow co-workers set out to guide her and let her know how to kick-off her career in technology transfer. I realised that over the relatively short amount of time I have been with a TTO (3 years), I got to learn about multiple opportunities.  So, I decided to write about all the opportunities I came to know about during my experience in this blog post, hoping it will be helpful for those who are just about to join our world of technology transfer.  

First thing I would recommend anyone joining a TTO office is to sign up with an ATTP association. If budgeting for membership is an issue, then at least sign up for the newsletters. For those who are based in the EU, the IPR helpdesk conduct multiple free of charge webinars. 4IPCouncil also conduct multiple webinars on IP. In addition, WIPO Academy conducts online IP courses, some of which are free. The WIPO Academy also selects a limited number of alumni who have read for their general distance learning (DL) course and advanced course to apply for scholarships covering travel and participation in a face-to-face training events. 

 

TTO Opportunities: Guest #blog by Michelle Cortis @UMmalta
"If you have #academic background in #lifesciences, @lifearc1 provides a yearly fellowship in #techtransfer. @inteum_company also tend to offer #scholarship for yearly conferences." Get more tips > https://t.co/ZwOa4bwfOt pic.twitter.com/EPrNWU4Bu8

— PraxisAuril (@PraxisAuril) February 14, 2020

Tweet to @PraxisAuril  Tweet #KEMatters


 

If you have an academic background in life sciences, LifeArc provides a yearly fellowship in technology transfer. It is an excellent programme which gives you a great insight on TT. Apart from this, Inteum also tend to offer scholarship for yearly conferences, including but not limited, to attend Praxil Auril yearly conference and the ASTP Annual conference. AUTM also have a yearly scholarship (the Howard Bremer Scholarship) which awards up to five people a free registration at the next conference. 

Erasmus+ is also an excellent opportunity for those who wish to avail themselves of an internship and/or placement within another office. Usually, travel and accommodation are covered for a maximum period of 2 months. 

In conclusion, my advice is to sign up with those associations that are of interest to you, follow different technology transfer blogs and keep updated through different media. 
 

Written by Michelle Cortis from the KTO of the University of Malta.

Feel free to contact Michelle on michelle.cortis@um.edu.mt should you wish to network with the Maltese Knowledge Transfer Office.

*The above has not been endorsed by any of the third parties mentioned.*
 

Home > Guest Blog

Written by Adam Stoten, Chief Operating Officer at Oxford University Innovation

Research England originally proposed the purpose of the KEF to be threefold:

  1. To provide universities with new tools to understand, benchmark and improve their performance.
  2. To provide businesses and other users with more information on universities.
  3. To provide greater public visibility and accountability.

Based on the consultation process feedback, it was clear that universities saw more value in (1) and (3), but overall the aims were deemed sensible. What the KEF wasn’t going to do in the first instance was act as a direct lever for government funding into universities. However, it seems that it is a question of when, rather than if, this will happen.

Much of the consultation centred on the suite of metrics to be used. The good news was that rather than focusing on the KE activities that tend to enjoy the most coverage in the press – i.e. spinouts – Research England attempted to define metrics that covered the full range of KE activities, spanning everything from business interactions to local regeneration to public and community engagement. This was critical if the KEF is to represent a framework for assessment that gives all UK HEIs an opportunity to shine in their particular areas of strength.

The other levelling mechanism, and a very sensible one at that, was to avoid comparing the likes of Cambridge University with the Liverpool Institute for Performing Arts. HEIs were instead clustered with peers, thus making comparisons within a group more appropriate.

So, what has changed as a result of the consultation process?

In terms of the HEI clusters, not very much. All but one of the original clusters remain, with the Social Sciences and Business specialists subsumed into the rest due to too small a sample size. This reflects a general welcoming of the approach by HEIs, albeit with some specific reservations about the cluster descriptions, the explanation of why institutions were clustered, residual variability within clusters and the potential to confuse industry.

In terms of metrics, the consultation process yielded plenty of feedback, but with a majority indicating that they represented an acceptable breadth of KE activity. While the seven high level categories below – called perspectives – remain unchanged, the underlying metrics have in many cases been amended. 

KEF perspectives:

  1. Research partnerships
  2. Working with business
  3. Working with the public and third sector
  4. Skills, enterprise and entrepreneurship
  5. Local growth and regeneration
  6. IP and commercialisation
  7. Public and community engagement

Most changes have centred on normalising the data for institutional size by HEI income, and in some cases differentiating between KE involving SMEs versus non-SMEs. There is also a major change regarding public and community engagement, with the previous metric being deemed unfit-for-purpose and an entirely new self-assessment metric to be developed in conjunction with the National Co-ordinating Centre for Public Engagement (NCCPE).

From an Oxford University Innovation viewpoint, the perspectives of most interest are those covering academic consultancy (‘Working with business’ and ‘Working with the public and 3rd sector’) and ‘IP and commercialisation’. The changes to the former are largely clarifications with HEI income normalisation and SME/non-SME differentiation added alongside the explicit inclusion of facilities and equipment income – and it’s great that these changes reflect some pretty consistent feedback from the consultation process.

However, the absence of a non-monetary-based metric for consultancy remains problematic and somewhat myopic in terms of accurately capturing the value and impact that consultancy activity can bring to an institution. In our experience, it can represent a low-cost, low-risk primer for more financially lucrative downstream collaborative activities such as industry-sponsored research or a Knowledge Transfer Partnership.

While flaws remain in the consultancy metrics, the change to the IP and commercialisation perspective is both the most baffling, and the most troubling. Two of the three associated metrics remain unchanged – ‘Average external investment per formal spinout’ and ‘Licensing and other IP income as a proportion of research income’. However, a new metric – ‘Estimated current turnover of all active firms per active spinout’ – replaces ‘Research resource (income) per formal spinout’. As a result, all IP and commercialisation metrics remain monetary.

The consultation process elicited quite strong responses regarding the significant imperfections of the original metrics, noting the various challenges with IP-related income – its lumpy nature, mostly deriving from a small number of HEIs, the time lag from a technology transfer “event” (i.e. a licence deal) to significant revenue, and the potential for a small number of high value deals or investments to skew an institution’s overall figures. 

The metric assessing ‘Licensing and other IP income as a proportion of research income’ is at particular risk of being skewed by a very small number of high value deals. Most technology transfer offices (TTOs) have portfolios characterised by a small number of high-earning deals and a long tail of low earning (but potentially high impact) licences. The presence of one or two very high value deals may be as much a result of serendipitous research activity or sectoral strength as an institution’s inherent KE capability. 

If the aim of a TTO is to efficiently transfer as much technology as possible then assessing research income per licensing transaction may be a better approach. Arguably an even more useful metric is research income per exclusive licensing transaction. Exclusive licensing typically presents a more challenging negotiation process as it will require the licensee to invest in developing, manufacturing, marketing and selling a product or service, versus non-exclusive licensing which may have a high transactional frequency based on repeat licensing of ready-to-go tools (e.g. software).

There is also in most cases a material delay between a licensing/spinout transaction and significant related financial returns, which means that any measure involving commercialisation income may at best reflect well upon historic competency in KE, rather than indicating current ability.

Focusing only on monetary metrics also ignores the growing critical mass of high impact but low income KE activity. At OUI we are seeing growing demand from academics for social enterprise vehicles to develop products and services arising from academic research. These ventures often require little in the way of external investment and are unlikely to generate large financial returns through licensing. However, they are potentially very impactful and the underlying ability of institutions to support this form of KE is likely to increase in importance, especially in relation to social sciences and humanities research.

The new metric regarding spinout turnover is particularly problematic, and has several shortcomings: 
  • It requires us to know the revenues of each spinout; this is likely to involve a great deal of extra work by institutions to comb through Companies House filings to determine accurate figures, which may not even be available there. 
  • It can/will be massively skewed by a small number of very high earning spinouts.
  • It reflects very poorly a university’s current ability to create new companies/ commercialise IP and instead reflects how well spinouts have been managed post-inception to get to a point where they are generating revenues – which may well be based on IP that has little to do with what was originally licensed from the university.
  • Most life science companies (certainly in the therapeutics space) will be acquired long before a product reaches the market/significant revenues are generated, so will never have significant turnover, even if their drug goes on to become a blockbuster. It is not clear what is reportable in this context.
If anything, this is more flawed than the metric it replaces.

Pausing for breath, I’m aware that the above complaints may fall under the category of First World problems – I’m pretty sure that Oxford will do ok under the new metrics even with the changes made. I’m also conscious that I’m grumbling about an area of KE that is truly relevant only to a minority subset of UK HEIs. So, what’s the big deal? Why get exercised about it?

Well, many of us who work in KE, and specifically in supporting the commercialisation of HEI-derived IP – have become accustomed to regular accusations from industry and investors of being fixated on wringing the last penny out of each transaction, and of over-valuing the IP for which we are seeking partners. In some cases, these accusations have some merit. However, in recent years I have without question witnessed a growing sophistication amongst TTOs and a prevailing focus on impact over income. This reflects both a maturing profession and the excellent training and development support from the likes of Praxis Auril. As a blanket criticism of TTOs, this now carries far less weight.

The reason that the KEF metrics cause me real consternation is that the solely monetary-based metrics risk pushing TTOs to focus more on revenue than impact, which would be an unfortunate and retrograde outcome. The potential of KEF to materially drive certain undesirable behaviours in TTOs will of course depend on how KEF is used by government to inform funding decisions. This remains unclear but should the KEF ultimately influence how, for example, Higher Education Innovation Fund resources are allocated, the threat may become much more real. As a member of an organisation that strives to support impactful KE projects irrespective of the likely monetary ROI, I would be saddened if an inadvertent consequence of the KEF was to reduce support for endeavours such as social enterprise at a time when demand amongst academics is growing.

One of the reasons given for the current metrics is that Research England wishes to minimise the data collection burden on HEIs by relying on data already collected as part of the Higher Education Business and Community Interaction (HEBCI) survey or via other statutory returns. Infuriatingly, the HEBCI survey already captures data that would enable more appropriate quantitative metrics, for example based on numbers of licences executed; a metric that would better reflect an institution’s current ability to find partners for its IP, that is agnostic to value and that does not exclude valuable activities like social enterprise.

The very fact that KEF exists is testament to the growing recognition by government that there is massive value – and still much unrealised potential – in supporting the exchange of knowledge between UK HEIs and partner organisations. Skilled workforces, new products, new companies providing new jobs, transformative policies, greater tax revenues, rejuvenated local ecosystems; all these can be products of HEI KE activity. 

It is only right that we ensure that HEIs can understand what they do well and where they could improve, that such information is transparent for businesses and the general public, and that it is acted upon. The KEF is a great step towards this, but it also represents a real opportunity to calibrate and align behaviours in a manner that results in positive outcomes. It would be a huge own goal if an exercise with such noble aims were to result in behaviours that are ultimately at odds with realising the incredible potential residing in our HEIs. 

To this end, I hope that Research England continues to consult with stakeholders – both public and private sector – to ensure that the KEF metrics benefit from further refinement and can be conducive to generating both impact and income.

Adam Stoten, Chief Operating Officer at Oxford University Innovation
 
Home > Guest Blog

 

Single access point

To support those companies, and those working in knowledge exchange, such as PraxisAuril members, the NCUB developed a simple idea: one digital access point to the wealth of knowledge within UK academia. konfer simplifies the start of the collaboration journey for firms by giving easy access to experts; research; grant funding opportunities; university equipment and facilities. And, our most recent addition is UK businesses we think are likely to be interested in innovating and working with universities. 

 
Latest release, latest tech

Konfer’s alpha and beta test releases proved the concept that the wealth of material available across the UK could be brought into one digital home. Machine learning and natural language processing in the latest release give even easier access to the host of information across 23 industry sectors in the UK. More than a million research papers, expert profiles and other data assets now incorporate topic and concept analysis, enabling unique search and discovery capabilities. And, an enhanced user experience facilitates konfer’s expanded capability connecting industry and academia.

 
Business Directory

We’re excited by the latest addition to konfer. The business directory includes businesses of all sizes from around the UK. Using konfer categories they can also be searched and filtered using a number of criteria. Using public data konfer has so far incorporated over 27,000 companies that we believe are likely to benefit from opportunities in relation to innovation grant funding and/or university collaboration, which is why we also include details of company research activities, including grant funded research, where available.

 
Sharing collaboration opportunities

Konfer is not just a static data set that can be intelligently interrogated, although it is obviously that. It also pushes out business-led collaboration opportunities to all UK universities and is now processing university led collaborations to ‘smart-match’ with sections of the business directory. Recent opportunities have ranged from a healthcare start-up, through an open innovation call from Severn Trent, to a £3 million grant fund from the Rail Safety and Standards Board.  And, any registered user can create new opportunities and respond to those already published. 

 
What’s next

Konfer is better than ever, but we want it to be more, so further features are in the pipeline to support our users in UK universities and businesses. An expanded funding module to promote more of the R&D funding opportunities available in the UK and an improved user dashboard are currently in development. All konfer’s development features aim to maximise engagement between universities and business, supporting the important work of Praxisauril members to help build a more innovative and inclusive future for the UK. 

Developed, operated and managed by the National Centre of Universities and Business (NCUB) in partnership with Research England and UK Research and Innovation (UKRI) konfer is free to use, so I encourage PraxisAuril members to explore konfer as a useful addition to your toolbox.

 

Home > Guest Blog

Guest blog by Adam Stoten PhD RTTP, Chief Operating Officer, Oxford University Innovation Ltd
Originally posted on LinkedIn

 

The result is a large number of new commercialisation projects each year, spanning everything from quantum computing to vaccines to autonomous vehicles to energy storage to speech recognition and so on. And plenty of AI of course. Some of these projects might have “spinout” written all over them from the outset, where they clearly have the potential to sustain a new venture, and indeed we create 20+ each year. Others might only ever be destined for repeat non-exclusive licensing to existing companies, for example the software research tools we licence via our online Software Store. Or some may have a very obvious home in a company with which the academic inventor already has a connection or collaboration.

There will also, every year, be a significant number of projects that don’t fit neatly in any of the above categories. On the face of it they are deserving of support; they appear to provide an economically and technically tractable solution to a meaningful problem; they have IP that we can protect or manage in a manner that should be conducive to finding a partner; and our preliminary market research has identified some target companies operating in the relevant business area.

Cue action from colleagues to generate non-confidential marketing profiles, identify and contact target companies and find one to which we can licence the IP and which will develop and market a product based on the Oxford invention. And this is where things get sticky. Many – if not most – of our projects are quite specialised and, although we endeavour to deploy proof of concept funding to advance them to a more mature Technology Readiness Level, many are still in need of significant development before a product or service can be sold. This immediately turns off a slew of companies which are interested only in finished products or those in late stage development.
Then we have the challenge of finding amongst the global panoply of potential licensees those for which:

  • the strategic fit is right
  • the technical fit is right
  • the risk profile is acceptable
  • the timing is right
  • sufficient financial resources are available to invest
  • the right person can be found to champion the deal

Finally, add in the sheer breadth of sectors that we cover and, even with a relatively large team, finding the needle in the haystack – aligning TTO “push” with company “pull” – can be a Herculean task.

 

What do our results tell us about the effectiveness of this marketing approach? OUI alum Richard Holliday recently posted an excellent LinkedIn article (https://www.linkedin.com/pulse/doing-deal-richard-holliday/) citing an analysis he led here a few years ago that looked at a cohort of 100 licence deals and identified the source of the partner for each. His results showed that about 25% of deals came from pre-existing academic contacts. However, a more recent analysis by my colleague Serena de Nahlik shows that this source of partners has grown year on year since the original study to nearly 50% in the period 2017-19. The same study indicates an increasing proportion of licensing deals to our spinout portfolio and a dwindling proportion of deals from our efforts to scour the market for potential partners.

How about marketing platforms? There are many such offerings, with the likes of InPart and TechConnect having garnered significant market share in recent times. While we endeavour to keep an open mind, it is fair to say that we have enjoyed very little success in terms of actual transactions being traced back to contacts made via such platforms, although there may be indirect benefits both from exposure of our IP and also in identifying organisations with an interest in the research which gave rise to the licensing opportunity. Ultimately there remains a reticence amongst the kind of large corporates that browse such platforms to take on the early stage opportunities we typically offer, no matter how loudly they trumpet their open innovation credentials.

 

So what is the solution to this challenge of getting our IP into the hands of partners who can take it to market and ultimately achieve impact? Magic bullets are unlikely to exist but one experiment that we piloted earlier this summer in Oxford might represent a glimmer of hope for a fundamentally different approach.

In collaboration with The Foundry (Oxford’s student entrepreneurship centre) and Oxford Sciences Innovation plc (a £600M venture fund focused on Oxford University), OUI launched StEP – our Student Entrepreneurship Programme. This programme brought together interested Oxford University students who self-assembled into multi-disciplinary teams around projects chosen from a pool of 30 from OUI’s portfolio. None of these projects were already being pursued as spinouts and many were in the “hard to shift” category. The teams then worked intensively during a 4 week period, supported by a stipend, to work up new venture proposals, supported by various mentors and with the chance of winning £25K at the end of it, courtesy of OSI. For any new venture arising, the students receive 90% of the founding equity, with the remaining 10% shared between the University and the academic originator of the IP (whose consent was required to make available the project in the first place).

We imagined the primary benefit of the programme would be giving the students entrepreneurial experience. However, the quality of new venture proposals from minds unencumbered by dogma or received wisdom was fantastic, and far surpassed our expectations. Not only is the winning project making great progress but others have gained new momentum and focus. The scheme was so successful that we are repeating it twice this academic year – see https://unistep.org/ .

It also shows the power of simply building a pool of local entrepreneurial demand in which the entrepreneurs are, within reason, agnostic as to the nature of a given project, provided that they can see a genuine commercial opportunity. Arguably this is precisely the approach that has led to the pre-eminent innovation ecosystems built around MIT and Stanford, where the cadre of entrepreneurs and investors provides the main “pull” for technologies, and the TTOs have historically provided little support beyond the licensing transactions.

 

One of Oxford’s great strengths is its intellectual capital and, while it may not quite have the number of entrepreneurs that Boston offers, we have an increasingly entrepreneurial student and research community, one of the world’s top business schools generating MBAs and Exec MBAs, and huge growth in the number of companies around the city. We also have a diverse alumni network, many of whom are accomplished entrepreneurs, and to this end there is a strong imperative for us to foster stronger links with Oxford’s colleges. The colleges are rightly sensitive about their own alumni relationship management but are also starting to embrace entrepreneurial support as a means of enhancing both alumni engagement and student experience.

The StEP model may not be the panacea for all TTO marketing woes but it represents a concept that has shown initial promise and which could have the potential to fundamentally alter how we connect IP to commercialisation partners. For instance, we are looking at how we could make available a wider range of projects and connect them to established and more experienced entrepreneurial networks. The StEP model could also lend itself to collaborative approaches between universities, especially smaller institutions that would otherwise struggle to achieve critical mass. With the first iteration of the Knowledge Exchange Framework (KEF) – intended to increase efficiency and effectiveness in all aspects of knowledge exchange – looming, it is perhaps a timely innovation.

We would love to hear from other institutions that have had experience with similar models, or indeed completely different approaches that have yielded success…

 

Acknowledgements: Thanks to Serena de Nahlik, Brendan Ludden and Simon Gray of OUI for their contributions.

 

Guest blog by Adam Stoten PhD RTTP, Chief Operating Officer, Oxford University Innovation Ltd
Originally posted on LinkedIn

 

Home > Guest Blog

 


 

Originally posted on the IN-PART website

 

What information do R&D teams look for in a project summary?

In most cases, translating an academic breakthrough into a new product, medicine or technological solution can’t be done without collaborating with industry. In universities, the office of technology transfer (TTO) or research commercialisation (ORC) will be tasked with the responsibility for making sure the right people in industry are alerted to relevant discoveries.

Getting the attention of R&D professionals involves cleverly packaging up complex scientific ideas and inventions into easily-digestible summaries. These project summaries, also known as technology disclosures, are designed so that an R&D professional can conduct a quick initial review to assess first, whether it’s relevant to their current research priorities, and then second, if it presents a unique solution to one of their R&D requirements.
 


 

To better understand what information is essential to include in a technology disclosure, in our annual survey we asked the R&D professionals who use IN-PART: ‘What is the most valuable piece of information for your assessments of whether a breakthrough or new technology from academia is relevant to your company?’. Three key elements came up in almost all of the responses we received (a full summary of the responses is included below):

 

Stage of development, or technology readiness level (TRL)

Explicitly stating the project’s current stage of development gives R&D teams an indication of how much — if any — work is required to incorporated it into the company’s R&D pipeline. It also allows the R&D team to assess whether they have the capacity to invest in testing/validation, prototyping, and further development.

Collaborating with a university requires a significant investment of time and resources for a company. Given the right opportunity, it’s worth the investment, but an academic breakthrough might be dismissed outright without the essential information about its stage of development.

 

Potential applications

For an invention to progress to being an innovation it has to be applied to create, or be implemented into, a product that holds market appeal. This potential is key to the decisions taken by R&D teams to in-license a technology, or to collaborate with the university to further develop the innovation.

Although academic researchers might be looking for companies to designate their own specific applications for their breakthrough, we have found that R&D teams like to see some sort of vision for the technology in its final form, with suggestions about how the technology might be used in those applications.

 

Cost-benefit and market analysis

What makes a new technology or breakthrough advantageous over an existing one? We learnt that providing an indication of the competitive landscape is essential to make it clear how a new breakthrough offers technical benefits over currently available technologies. In addition, giving a brief, informed indication of the market demand and economic value of a technology provides an incentive for R&D professionals to take the time to evaluate an opportunity further. Also, R&D teams can sometimes be willing to shift focus from their core interests if it’s clear for them to see the potential economic value of the technology for their company.

The requirement to outline the benefits of a new technology over an existing one, and to provide an economic analysis, was also highlighted in a blog that we published earlier this year: ‘How do R&D teams evaluate new opportunities?’.

Ronan Bellabarba, Technology Manager at Johnson Matthey, an industry leader in speciality chemicals and sustainable technologies, outlined this outlook, saying that:

“There are certain critical points of information which are necessary to establish relevance. These are obviously the fit with my company’s existing, or potential, technology and markets, but also what problem does the technology solve, and how is this better than existing solutions?”

“The critical point for an initial evaluation is to have some kind of economic comparison against the leading competing solution to that problem. The ‘hook’ that gets a company interested is often presented as technical, but needs to be commercial; it also has to be credible. These calculations are not difficult but increase the impact by orders of magnitude.”

 

What else does industry want to know?

As the responses to our survey show (below), there are other pieces of information that are essential for R&D teams in industry. Making it clear exactly what the technology, project or breakthrough is, with a concise and informative title, and a description that ticks all the boxes means that R&D professionals can make a clear decision about its relevance to their work. This also helps IN-PART’s research team to more accurately match the breakthrough to the widest range of companies with aligned R&D interests.

R&D professionals also value seeing key technical details and data that demonstrate the feasibility or proof-of-concept of a technology. Including the intellectual property (IP) status and links to any patents can make the difference between the company taking the time to look into an opportunity and immediate dismissal.
 


 

Figure 1: IN-PART survey responses — ‘What is the most valuable piece of information for your assessments of whether a breakthrough or new technology from academia is relevant to your company?’ [January 2019, open question, 63 respondents]

 

Top tips for effectively communicating science to industry
 


 

Getting across all this information in a succinct, simple and engaging way for a global audience that might include non-specialists is not a small ask, but there are steps that can be taken to increase the chances of success. Briefly outlining the who, what, where, why, and how in the introduction is an effective way to cover much of the essential information required, followed by an expansion on these points through the rest of the technology disclosure.

Creating a story is a proven way to optimise engagement with scientific research. Writing about why the researchers have been working to develop a much-needed solution, and how they’ve been doing that, highlights why it’s also worth the time of passing R&D professionals.

If there’s an analogy that can be found with a global reference point, this can also cut down the words needed to describe a concept and quickly get across the gist of a complex idea. For example, you might describe a new drug delivery system for a tumour-targeting immunotherapy drug as a trojan horse to fight cancer, or you might summarise the AI-algorithms behind a reasoning engine for massive datasets as a Google Maps for decision making.

Adding links to further information is useful for keeping the summary short. The adage that a picture speaks a thousand words is often true. A video can say even more.

Finally, it’s important to keep in mind that it’s not necessary (and often unfeasible) to try and provide every detail about a project in 400–600 word summary. Providing the minimum essential information to capture enough interest from an R&D professional to ask further questions is a smart way of encouraging a request for more information that opens the door to a productive discussion.

 

Examples of successful technology disclosures on IN-PART

The following innovations are a select handful from the 230+ universities and research institutes using IN-PART that have received high levels of engagement from industry. They’re great examples of different approaches to providing a succinct summary of a project that successfully incorporates why the research is needed, how that’s been achieved, and what its future potential could be.

Exactly what the technology is and how it works has been clearly stated, and the all-important potential applications are outlined. Additionally, figures to illustrate key data, and links to further information such as publications and patents are included:

  • Coating Mild Steel with Graphene for Corrosion Protection (Monash University)
  • Anti-CCR6 mAb for Autoimmune Diseases (Monash University)
  • Live-Attenuated Salmonella enterica Vaccine (North Carolina State University)
  • Ultra-high Temperature Ceramics (University of Birmingham)

 

Written by Sharon Gill from IN-PART’s Research Team.

Edited by Alex Stockham, IN-PART’s Communications Manager.

 

Originally posted on the IN-PART website

Home > Guest Blog

 

GUEST BLOG by Dr Odette Dewhurst
Senior Research Development Manager (Life Sciences, Health, Medicine) at Lancaster University
 


‘I know Kung Fu’ Neo

 

Sadly, unlike the crew of the Nebuchadnezzar in the Matrix, we can’t simply plug ourselves into training programmes and download the content directly into our brains. It would be quite nice if we could, but we can’t. At least not yet…..

 

Why is staff development important? What do we mean by it? 

‘They say a little knowledge is a dangerous thing, but it's not one half so bad as a lot of ignorance’ Terry Pratchet

Over the years, I’ve read countless fellowships/career development grant applications where the applicant has something along the lines of: ‘I will develop my leadership skills by attending my University’s leadership and management courses’ as if development works like osmosis and simply by being physically in a room where training is happening, we automatically learn new skills.

Formal training sessions, courses etc. are very useful and important, but development is much more than this. To learn and develop, we have to practice what we have heard and talked about in a workshop or training programme. Last year, I undertook training to become an ILM5 coach. There were around 20 of on the course and although the programme was several months in duration, intensive and had significant assignments to complete, we all agreed that it was a bit like learning to drive. We learn the skills needed to pass the test, but it’s only once we pass/qualify and start actually doing it for real, on our own, that we truly learn how to do it and develop. 
 

It is important for any organisation to engage with and invest in, the development its staff. It helps people do their jobs more effectively, helps them to develop as individuals and progress in their careers. I think it also makes us feel more valued by our organisation if it encourages and supports us to take time away from ‘the day job’ to learn something new or develop a new skill.
The words ‘training’ and ‘development’ are sometimes used interchangeably but there are differences. Generally speaking, ‘training’ focuses more on the present, on an individual learning how to do something specific. It might take the form of training that is required for an individual/organisation to comply with specific regulation, such as health and safety or GDPR. It might be training in how to use a piece of software. It’s how to ‘do’, rather than how to ‘be.’

As training focuses on the role, ‘development’ is more likely to focus on the individual and looks to prepare that individual for the future, not just for their current role. As with the coaching programme, we were taught about the underpinning theory and models but putting those into practice, feeling comfortable with active listening and knowing how and when to put forward questions, they are skills that can only be developed over time and with practice. Each time I meet a coachee and with each new coachee I work with, I feel more comfortable in the role. I learn, tweak things and gain in confidence – whilst knowing that I still have much to learn.

 
Comfort, Stretch – Panic!

We often hear about Karl Rohnke’s model of ‘comfort, stretch, panic’ in discussions around training and development. If you’ve not heard of it, the idea is that when we’re in our comfort zone, we aren’t learning or progressing. We’re just ticking along, on auto-pilot and not really having to think much. It’s easy. It’s a safe place but one that can become boring and offers little opportunity for innovation and creativity. When we’re pushed out of our warm and fluffy ball of comfort and into a position of stretch, that’s when we learn. We might pop into the stretch zone and then pop back into our ball of comfort, but that’s fine – we reflect, we learn, we ponder. Then we go back into stretch and push ourselves, try new things and learn. That’s where creativity and innovation are mostly found. When we step too far out of our comfort zone though, that’s when panic hits. It’s hard to learn when we’re so far out of our comfort zone. A recent example of this was when some friends and colleagues attended what they expected to be a preparatory discussion ahead of a stand-up comedy event for academics. The friends who were at the session weren’t there to do stand-up, they were there to listen and find out more about the event. To most of their horror, they were asked to stand up and be funny for a minute. For at least one of them, that was fully in ‘panic!’ and she reflected afterwards that it was worse than childbirth and absolutely hated it and felt stressed by it. We’re all humans and we’re all different, which means that our boundaries between comfort, stretch and panic are all different.
 

 
MANAGING EXPECTATIONS 

One of the challenges, particularly in leadership courses and programmes is to manage the expectations of what opportunities are available following the training. For those of us in professional services, where career progression opportunities are limited – particularly the higher up the salary scales we get – not everyone who participates in a flagship leadership programme will have the opportunity to implement what they’ve learned. How then do we manage that expectation? It may well be that often, organisations effectively train people to leave – to move role, but as Henry Ford is reputed to have said “The only thing worse than training your employees and having them leave is not training them and having them stay.”  Some universities manage expectation and utilise the skills and expertise of those who’ve undergone leadership development, by inviting them to take on voluntary roles/secondments, through which staff can stretch themselves by trying something new. By doing this, staff gain vital experience of leading on specific projects and continuing to develop their leadership skills, without formally changing role.

 

YOU CAN’T PLEASE EVERYONE ALL OF THE TIME

Over the years, I have developed, delivered and evaluated a myriad of training and development sessions – different universities, different career stages, different topics. One thing I learned early on is that you can’t please everyone all of the time. Reading feedback forms, I’m always struck by the fact that any given session might be simultaneously too long and too short. Some might find the interactive bits brilliant, whilst others hated them. Whilst much of the feedback can be helpful, and plays a key role in developing future iterations of a course/workshop, some – can just leave a facilitator scratching their head in bewilderment. Having said that, if the only thing someone didn’t like about a workshop is the biscuits or curtains in the room (the offending curtains were, to fair – ripped and rather grubby) then the content and format of the session must have been fine. Or, at least better than the curtains and biscuits. 

Speaking of food, for me that’s one of the worst parts of attending training or development courses/programmes. Sometimes the food has been amazing, but often it’s the standard ‘sandwiches with slightly random and often unidentifiable fillings and a random bit of fruit’ offering. Served alongside some strange brown liquid which may or may not be coffee.  However, catering is expensive and very often staff development sessions (particularly in-house offerings) are done within tight budget constraints. 
 

Money

In a world where budgets are being squeezed and we all have to justify expenditure more and more, staff development can be one of the first things to be cut. It can be challenging, if not impossible to be able to state definitively that by spending a certain amount on an employee to go and attend a conference or take part on a development programme, it will result in a saving or return of £X and is therefore financially worth it.

 

It’s not just about courses and programmes

We don’t always need to go on formal programmes and courses to develop. Sometimes it’s about volunteering to do something different – sit on a new working group, chair a committee, write a blog, mentor people, embrace the dreaded networking thing at conferences and talk to new people, give presentations, read about something new and different. Push ourselves out of ‘comfort’ and into ‘stretch’ and see what happens.

 

Tank, I need a pilot program for a V-212 helicopter…

 

 
GUEST BLOG POST by Dr Odette Dewhurst
Senior Research Development Manager (Life Sciences, Health, Medicine) at Lancaster University

 

Posts navigation

Older posts
Knowledge Exchange Logo
Quick Links
  • About Us
  • What is KE?
  • KE Connect
  • Jobs Board
  • Contact
Membership
  • Why join us?
  • Become a member
  • Members Directory
  • Member events
CPD
  • Training Courses
  • In-House Training
  • Workshops
  • Become a Volunteer
  • Course Trainers
  • Moodle LMS
Events
  • Conference
  • KE Awards
  • Directors’ Forum
  • Events
Legal
  • Terms & Conditions
  • Events T & C
  • Privacy Policy
  • Cookies
Follow Us
© Knowledge Exchange UK 2026 | Co. Registration no. 05090806 | VAT no. GB292701793
Membership Website Design | Douglass Digital

Subscribe to our Newsletters

Sign up to the Knowledge Exchange UK newsletter for for news, training, jobs and event updates.

First Name:*
Last Name:*
Email:*
Organisation:*
Job Title:*